Sushant Kachhap

Medicine & Life Sciences

1. Prostatic Neoplasms 100%
2. Histone Deacetylase Inhibitors 47%
3. Androgens 39%
4. BRCA1 Gene 37%
5. Cell Line 29%
6. Castration 28%
7. Growth 25%
8. MCF-7 Cells 21%
9. PC-3 Cells 20%
10. Neoplasms 18%
11. Hypoxia-Inducible Factor 1 18%
12. Down-Regulation 17%
13. Genes 16%
14. Mitochondrial DNA 16%
15. Histone Deacetylases 15%
16. Androgen Receptors 15%
17. Therapeutics 15%
18. MDV 3100 14%
19. Testosterone 14%
20. N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1-phthalazinamine 14%
21. Valproic Acid 14%
22. Prostate 13%
23. Breast Neoplasms 13%
24. Gene Expression 13%
25. tasquinimod 13%
26. Recombinational DNA Repair 13%
27. Hypoxia 12%
28. Autophagy 12%
29. Linoleic Acid 12%
30. Tilorone 11%
31. vatalanib 11%
32. Heterografts 11%
33. Mutation 11%
34. Cell Cycle Checkpoints 11%
35. Tumor Suppressor Genes 11%
36. HSP40 Heat-Shock Proteins 10%
37. Mitochondria 10%
38. Vorinostat 10%
39. Ferroptosis 10%
40. E2F1 Transcription Factor 10%
41. Uracil-DNA Glycosidase 10%
42. Trigonella 10%
43. Cetrimonium 10%
44. Aurora Kinases 10%
45. polo-like kinase 1 9%
46. Communication 9%
47. Cyclin-Dependent Kinase 5 9%
48. Synthetic Lethal Mutations 9%
49. Proteins 9%